Fontan-associated protein-losing enteropathy and plastic bronchitis

Journal of Pediatrics

Volumn 166, Issue 4, 2015, Pages 970-977

  Schumacher, Kurt R ^a   Stringer, Kathleen A ^b   Donohue, Janet E ^a   Yu, Sunkyung ^a   Shaver, Ashley ^a   Caruthers, Regine L ^a   Zikmund Fisher, Brian J ^c   Fifer, Carlen ^a   Goldberg, Caren ^a   Russell, Mark W ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; HEPARIN; OCTREOTIDE; PREDNISONE; SILDENAFIL; SPIRONOLACTONE; WARFARIN;

ADOLESCENT; ALLERGY; ARTICLE; BRONCHITIS; CHILD; CHYLOTHORAX; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE COURSE; FEMALE; FONTAN PROCEDURE; HEART LEFT VENTRICLE HYPOPLASIA; HEART RIGHT VENTRICLE HYPOPLASIA; HEART SINGLE VENTRICLE; HEART TRANSPLANTATION; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPOPLASIA; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MYOCARDIAL DISEASE; PALLIATIVE THERAPY; PLASTIC BRONCHITIS; PRIORITY JOURNAL; PROTEIN DIET; PROTEIN LOSING GASTROENTEROPATHY; THORAX SURGERY; ADVERSE EFFECTS; FOLLOW UP; HEART DEFECTS, CONGENITAL; INCIDENCE; PILOT STUDY; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PROTEIN-LOSING ENTEROPATHIES; RISK FACTOR; UNITED STATES;

ADOLESCENT; BRONCHITIS; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HUMANS; INCIDENCE; MALE; MICHIGAN; PILOT PROJECTS; POSTOPERATIVE COMPLICATIONS; PROTEIN-LOSING ENTEROPATHIES; RISK FACTORS;

EID: 84933277431     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.12.068     Document Type: Article

References (22)

1. Racz J, Mane G, Ford M, Schmidt L, Myers J, Standiford TJ, et al. Immunophenotyping and protein profiling of fontan-associated plastic bronchitis airway casts. Ann Am Thorac Soc 2013;10:98-107.
2. Rychik J. Protein-losing enteropathy after fontan operation. Congenit Heart Dis 2007;2:288-300.
3. Mertens L, Hagler DJ, Sauer U, Somerville J, Gewillig M. Protein-losing enteropathy after the fontan operation: an international multicenter study. PLE study group. J Thorac Cardiovasc Surg 1998;115:1063-73.
4. Larue M, Gossett JG, Stewart RD, Backer CL, Mavroudis C, Jacobs ML. Plastic bronchitis in patients with Fontan physiology: review of the literature and preliminary experience with fontan conversion and cardiac transplantation. World J Pediatr Congenit Heart Surg 2012;3:364-72.
5. Madsen P, Shah SA, Rubin BK. Plastic bronchitis: new insights and a classification scheme. Paediatr Respir Rev 2005;6:292-300.
6. Meadows J, Jenkins K. Protein-losing enteropathy: integrating a new disease paradigm into recommendations for prevention and treatment. Cardiol Young 2011;21:363-77.
7. Caruthers RL, Kempa M, Loo A, Gulbransen E, Kelly E, Erickson SR, et al. Demographic characteristics and estimated prevalence of fontanassociated plastic bronchitis. Pediatr Cardiol 2013;34:256-61.
8. Gossett JG, Almond CS, Kirk R, Zangwill S, Richmond ME, Kantor PF, et al. Outcomes of cardiac transplantation in single-ventricle patients with plastic bronchitis: A multicenter study. J Am Coll Cardiol 2013; 61:985-6.
9. Schumacher KR, Stringer KA, Donohue JE, Yu S, Shaver A, Caruthers RL, et al. Social media methods for studying rare diseases. Pediatrics 2014;133:e1345-53.
10. Anderson PA, Sleeper LA, Mahony L, Colan SD, Atz AM, Breitbart RE, et al. Contemporary outcomes after the Fontan procedure: A pediatric heart network multicenter study. J Am Coll Cardiol 2008;52:85-98.
11. Hirsch JC, Goldberg C, Bove EL, Salehian S, Lee T, Ohye RG, et al. Fontan operation in the current era: A 15-year single institution experience. Ann Surg 2008;248:402-10.
12. Chaudhari M, Stumper O. Plastic bronchitis after fontan operation: treatment with stent fenestration of the fontan circuit. Heart 2004;90: 801.
13. Feldt RH, Driscoll DJ, Offord KP, Cha RH, Perrault J, Schaff HV, et al. Protein-losing enteropathy after the fontan operation. J Thorac Cardiovasc Surg 1996;112:672-80.
14. Powell AJ, Gauvreau K, Jenkins KJ, Blume ED, Mayer JE, Lock JE. Perioperative risk factors for development of proteinlosing enteropathy following a Fontan procedure. Am J Cardiol 2001;88:1206-9.
15. Schumacher KR, Singh TP, Kuebler J, Aprile K, O'Brien M, Blume ED. Risk factors and outcome of fontan-associated plastic bronchitis: A casecontrol study. J Am Heart Assoc 2014;3:e000865.
16. Meadows J, Gauvreau K, Jenkins K. Lymphatic obstruction and proteinlosing enteropathy in patients with congenital heart disease. Congenit Heart Dis 2008;3:269-76.
17. Ezmigna DR, Morgan WJ, Witte MH, Brown MA. Lymphoscintigraphy in plastic bronchitis, a pediatric case report. Pediatr Pulmonol 2013;48: 515-8.
18. Parikh K, Witte MH, Samson R, Teodori M, Carpenter JB, Lowe MC, et al. Successful treatment of plastic bronchitis with low fat diet and subsequent thoracic duct ligation in child with Fontan physiology. Lymphology 2012;45:47-52.
19. Ostrow AM, Freeze H, Rychik J. Protein-losing enteropathy after fontan operation: investigations into possible pathophysiologic mechanisms. Ann Thorac Surg 2006;82:695-700.
20. Kolcz J, Tomkiewicz-Pajak L, Wojcik E, Podolec P, Skalski J. Prognostic significance and correlations of neurohumoral factors in early and late postoperative period after fontan procedure. Interact Cardiovasc Thorac Surg 2011;13:40-5.
21. Thacker D, Patel A, Dodds K, Goldberg DJ, Semeao E, Rychik J. Use of oral budesonide in the management of protein-losing enteropathy after the fontan operation. Ann Thorac Surg 2010;89:837-42.
22. Schumacher KR, Cools M, Goldstein BH, Ioffe-Dahan V, King K, Gaffney D, et al. Oral budesonide treatment for protein-losing enteropathy in fontan-palliated patients. Pediatr Cardiol 2011;32:966-71.